A surgeon who couldn't walk

Dr. Gaetano Scuderi was an orthopedic surgeon. Then a motorcycle accident knocked him down for seven years.

He couldn’t operate. He couldn’t walk right. So he sat and thought.

He kept coming back to one question… it’s so obvious you wonder why nobody asked it before. Why does cartilage break down?

The osteoarthritis industry is worth $560 billion. Yet nobody had a good answer.

Scuderi’s team found one. They discovered a protein — your body already makes — that protects joint cartilage from the enzymes that eat it away. The problem is your body doesn’t produce enough of it inside the joint… where it actually matters.

So they developed a therapeutic version that can be mass-produced and injected directly into the knee.

More than 10,000 patients have already been treated with this first-generation therapy. The synthetic version just cleared Phase 1 FDA clinical trials with zero reported adverse events.

If the early data hold up, this would be the first treatment that prevents osteoarthritis from getting worse… not just covers up the pain.

More than 7,000 investors have put $3932 million behind the company so far. Some of them are professional athletes… people whose careers depend on healthy joints.

You can see the full details — and invest — by clicking here.

Disclaimer: This is a paid advertisement for Cytonics Regulation CF offering. Please read the offering circular at https://invest.cytonics.com. Forward-looking statements are subject to risks and uncertainties. There is no guarantee of performance. Past performance does not predict future results. All investments involve risk, including loss of principal.